Proteomics International Laboratories (PIQ) Stock Overview

Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research. The company was founded in 2001 and is based in Perth, Australia.

PIQ Stock Information

Symbol

PIQ

Address

QEII Medical CentrePerth, WA 6009Australia

Founded

Trading hours

10:00 AM - 4:00 PM AEST

Website

https://www.proteomics.com.au

Country

🇦🇺 Australia

Phone Number

61 8 9389 1992

Proteomics International Laboratories (PIQ) Price Chart

Proteomics International Laboratories Overview: Key Details and Summary

Stock data	2023	Change
Price	$0.53382933576858	N/A
Market Cap	$62.17M	N/A
Shares Outstanding	116.45M	10.35%
Employees	0	N/A
Shareholder Equity	8.32M	145.25%

Valuation	2023	Change
P/E Ratio	-9.98	N/A
P/S Ratio	126.76	N/A
P/B Ratio	7.47	N/A

Growth	2023	Change
Return on Equity	-0.5030	N/A

Earnings	2023	Change
Revenue	$490.41K	N/A
Earnings	-$4.19M	N/A
EPS	-0.0535	N/A
Earnings Yield	-0.1002	N/A
Gross Margin	1.00	N/A
Operating Margin	-12.07	N/A
Net income margin	-8.54	N/A

Financial Strength	2023	Change
Total Assets	$6.77M	N/A
Total Debt	$43.03K	N/A
Cash on Hand	$4.05M	N/A
Debt to Equity	0.1414	-64.32%
Cash to Debt	$94.05	N/A
Current Ratio	$7.55	194.55%